CNRS Technologies

Find the best CNRS technologies to boost your innovative project.

Les brevets les plus récents

You are a research scientist?

We can guide you through the whole technology transfer process.

See all our services

You are a corporate player?

Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.

Contact us

Follow our news and upcoming events

Discover CNRS technologies

Meet our team


Natural compounds activating Sirt1 for the cellulite treatment




Skin care

Statut des brevets

Priority patent FR1257598 filed on 03/08/2012. Entitled “Nouveaux composés activateurs de l’activité enzymatique de Sirt1 et compositions phamaceutiques ou cosmétiques les comprenant”

EP13765519.7 filed on 02/08/2013


Joanna Bakala
Jérôme Bignon
Jian-Miao Liu
Maria-Conception Achab
Catherine Guillou

Statut commercial

Exclusive or non-exclusive licenses, Collaborative agreement


ICSN, (UPR2301, CNRS) Gif sur Yvette, France.



The sirtuin family concerns nuclear NAD+ dependant deacetylases, playing an important role in deacetylation of histones.
Sirtuin 1 is the best known situin. It is involved in an important number of metabolic processes. It has several target as p53, FoxO, PPAR gamma, PGC1 alpha, UCP2, LXR and Ku70, key regulating proteins in cell functions.
Sirt1 has a global anti-aging effect.
The Sirt1 expression decreases along the lifetime.
Sirt1 has also a role in adipogenesis and lipid accumaltions. The lipolysis is increased by activating Sirt1 activity.


The invention concerns new natural compounds, with a steroid structure, for dermo-cosmetic applications.
These compounds are vegetal steroides.
They show a stimulation activity towards the enzyme Sirtuin 1 (Sirt1), involved in lipid metabolism and aging.
In vitro experiments showed that the compounds are able to inhibit adipogenesis, to enhance lipolysis, and that they have an anti-inflammatory effect.
As vegetal steroid, tests have been made to check their potential interactions with eostrogen and testosteron receptors. The study showed that no interaction occurs with these receptors and undesirable side effects should thus be limited.
A study on model animal (sirt Knock out mice) showed that the compounds had no effect on the animals and that the activity of the compounds is 90% dedicated to Sirt1 activation.


These new compounds could have an interest for cellulite treatment and sub-cutaneous accumulations and the related inflammation.
They could be incorporated in cosmetic preparations to slow the skin aging process.

For further information, please contact us (Ref 04703-01)

Besoin de plus d'informations ?

Nous contacter


  • This field is for validation purposes and should be left unchanged.

Les brevets les plus récents